Skip to main content

Publication, Part of

Adolescent and Young Adult Type 1 Diabetes Audit (AYA), 2017-21

Future publication format

Please note that future publications will be web-based only. This is to improve the accessibility of our publications.

16 June 2022 09:30 AM

Change to inclusion of drug prescription and diabetic ketoacidosis (DKA) data for Wales

In the Interactive data visualisation published on 16 June 2022 Wales drug prescription data was not included in the diabetes diagnosis validation process. In v2.0 of the visualisation this data has been included resulting in a larger cohort used for the analysis, particularly for Wales. For further details on the diagnosis validation process see main report.

 

In addition, v2.0 no longer includes analysis on DKA hospital inpatient admissions for Wales. This is because it was only possible to obtain data NHS hospital admission data from hospitals in England and therefore any DKA hospital inpatient admission results for Wales would not have been representative of diabetes care in Wales.

18 July 2022 09:00 AM

Changes to NDA reporting

NHS England are currently reviewing the routine production of NDA State of the Nation reports. Please note that data will still be released via dashboards and standalone data files whilst this review is being conducted.

To help inform this review we would be grateful if users can provide feedback on their use of the State of the Nation reports using the feedback survey available in the ‘Related links' section of this page.

3 June 2024 00:00 AM

Page contents

Additional Information

Definitions

Diabetes

Diabetes is a condition where the amount of glucose in the blood is too high because the pancreas doesn’t produce enough insulin.  Insulin is a hormone produced by the pancreas that allows glucose to be used as a body fuel and other nutrients to be used as building blocks. There are 2 main types of diabetes: type 1 diabetes (no insulin); type 2 diabetes (insufficient insulin).

Specialist Service

This is a service (often hospital based but sometimes delivered in a community setting) which includes diabetes specialists working in multidisciplinary teams. These teams usually comprise physicians (diabetologists), diabetes specialist nurses and dieticians; it may also include clinical psychologists.

Insulin pump

Insulin pump or Continuous Insulin Infusion therapy uses rapid acting insulin delivered subcutaneously under the control of a ‘Pump’. Background rates are programmed and mealtime boluses are added manually.

Adolescents and young adults

For the purposes of this report adolescents are people aged 15 to 18 years old. Young adults are people aged 19 to 25 years old (inclusive).

Care Processes (National Institute for Health and Care Excellence - NICE - recommends all of these at least once a year)

Blood Pressure is a measurement of the force driving the blood through the arteries. Blood pressure readings contain 2 figures, e.g.130/80. The 1st is known as the systolic pressure which is produced when the heart contracts. The 2nd is the diastolic pressure which is when the heart relaxes to refill with blood.

BMI measurement - Body Mass Index (BMI) is calculated from weight and height. Methods differ between children (up to 18 years old) and adults. In adults, categories are assigned on BMI ranges. For children, their BMI is compared to reference values for children of the same sex and similar age that took part in national surveys. Assignments for both groups are:

Category Children (Centile) Adults  (BMI value)
Underweight <= 2nd centile <18.5
Healthy weight > 2nd and < 85th centile 18.5 to 24.9
Overweight >= 85th and <95th centile 25 to 29.9
Obese >= 95th centile >= 30

Serum creatinine - this is a blood test used to measure kidney function.

Urinary albumin - this urine test detects the earliest stages of kidney disease.

Cholesterol - this blood test measures a type of fat that can damage blood vessels. This is not a mandated care process for adolescents and young adults.

Foot check/exam - this examination checks the blood supply and sensation (feeling) in the feet. Loss of either is a risk for foot disease.

Smoking Status - this records whether the person is a smoker. Smoking increases the diabetic risk for heart attacks and stroke.

HbA1c - this is a blood test for average blood glucose levels during the previous 2 to 3 months.

Urine Albumin-to-Creatinine Ratio (UACR)

UACR is a ratio between 2 measured substances urine albumin and urine creatinine. Unlike a urine dipstick test for albumin, UACR is unaffected by variation in urine concentration.

Treatment Targets (NICE defines target levels to reduce risks of complications for people with diabetes)

HbA1c - the closer this is to normal (less than 42mmol/mol) the lower is the risk of all long term complications of diabetes.

Cholesterol - reducing cholesterol levels lowers the risk of heart attacks and strokes.

Blood Pressure - high levels are a risk for heart attacks and strokes; they also drive progression of eye and kidney disease.

Diabetic ketoacidosis (DKA)

It is a potentially life-threatening complication of predominantly type 1 diabetes that occurs when insulin levels become very low. As a result of the lack of insulin the body is unable to store or use blood sugar (glucose) which rises uncontrollably. Fat is broken down to use as an alternative energy source but in an uncontrolled fashion. This causes a build-up of potentially harmful, acidic, ketones. The high glucose and ketone levels lead to excessive urination, vomiting, dehydration, low blood pressure and collapse/coma. Without treatment DKA is fatal.

Notes and Additional Information

Time period covered
  • Custom image The National Paediatric Diabetes Audit (NPDA) years covered are 2017-18 to 2019-20 which covers the period 01 April 2017 to 31 March 2020.
  • Custom image The National Diabetes Audit (NDA) years covered are 2017-18 to 2020-21 which covers the period 01 January 2017 to 31 March 2021. 2020-21 data is included to provide data on people in the 2019-20 NPDA who then transferred to adult services.
Suppression
  • Custom image Disclosure control has been applied to mitigate the risk of patient identification. Zeros are reported, and all numbers are rounded to the nearest 5, unless the number is 1 to 7, in which case it is rounded to ‘5’. This allows for more granular data to be made available.
  • Custom image Rounded numbers are used to calculate percentages such as care process completion and treatment target achievement. Consequently totals may not sum.
  • Custom image At Clinical Commissioning Group (CCG)/Local Health Board (LHB) level and above the use of rounded numbers makes virtually no difference to the resultant percentages. However, where numbers are small, percentages are volatile and should already be treated with caution.

National Diabetes Audit, 2017-21 Adolescent and Young Adult Type 1 Diabetes

Published by NHS Digital

Part of the Government Statistical Service

 

For further information

https://digital.nhs.uk

0300 303 5678

[email protected]

 

© 2022 NHS Digital. All rights reserved.

NHS Digital is the trading name of the Health and Social Care Information Centre.

This work may be re-used by NHS and government organisations without permission.



Last edited: 3 June 2024 10:34 am